HIKMA Pharmaceuticals PLC
HIK | XLON
Overview
Corporate Details
- ISIN(s):
- GB00B0LCW083
- LEI:
- 549300BNS685UXH4JI75
- Country:
- United Kingdom
- Address:
- 1 New Burlington Place, W1S 2HR London
- Website:
- https://www.hikma.com/home/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Hikma Pharmaceuticals PLC is a global pharmaceutical company that is dedicated to providing high-quality, affordable medications to patients worldwide. With its headquarters in London, UK, and operations in the Middle East, Africa, Europe, and the United States, Hikma has established itself as a leader in the pharmaceutical industry. The company has a diversified product portfolio that includes branded, generic, and injectable pharmaceuticals. Its focus is on developing and manufacturing innovative solutions for complex diseases, such as oncology, respiratory, and injectables.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-05 15:05 |
Directors' Dealings
Director/PDMR Shareholding
|
English | 14.4 KB | |
| 2025-06-03 14:02 |
Directors' Dealings
Director/PDMR Shareholding
|
English | 89.1 KB | |
| 2025-05-29 08:00 |
Regulatory News Service
Fitch upgrades Hikma to ‘BBB’
|
English | 11.3 KB | |
| 2025-05-15 13:00 |
Regulatory News Service
Medium-term Group guidance ahead of US site visit
|
English | 12.5 KB | |
| 2025-05-08 11:48 |
Regulatory News Service
S&P upgrades Hikma to ‘BBB’
|
English | 11.3 KB | |
| 2025-05-08 09:21 |
Regulatory News Service
Settlement agreement for Xyrem® US lawsuits
|
English | 15.2 KB | |
| 2025-04-30 14:21 |
Directors' Dealings
Director/PDMR Shareholding
|
English | 27.3 KB | |
| 2025-04-24 18:16 |
Regulatory News Service
Special Business passed at AGM
|
English | 329.0 KB | |
| 2025-04-24 16:55 |
AGM Report
Result of AGM
|
English | 48.9 KB | |
| 2025-03-19 11:10 |
Annual Report
Annual Financial Report and Notice of AGM
|
English | 10.4 KB | |
| 2025-03-19 11:10 |
AGM Report
Notice of 2025 Annual General Meeting
|
English | 827.6 KB | |
| 2025-03-19 11:07 |
Annual Report (ESEF)
2024 Annual Report and Accounts
|
English | 9.8 MB | |
| 2025-03-19 11:07 |
Annual Report
2024 Annual Report and Accounts
|
English | 18.6 MB | |
| 2025-03-04 12:16 |
Directors' Dealings
Director/PDMR Shareholding
|
English | 63.1 KB | |
| 2025-02-26 08:00 |
Annual Report
Final Results
|
English | 797.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Halychpharm | Ukraine | GFARM | |
|
Hamlet BioPharma AB | Sweden | HAMLET | |
|
Harm Reduction Group AB | Sweden | NOHARM | |
|
Heidelberg Pharma AG | Germany | HPHA | |
|
HELLENIC DYNAMICS PLC | United Kingdom | HELD | |
|
H. Lundbeck A | Denmark | HLUN | |
|
Hod-Assaf Industries Ltd. | Israel | HOD | |
|
HUDDLED GROUP PLC | United Kingdom | HUD | |
|
Iconovo AB | Sweden | ICO | |
|
iDNA Genomics Public Ltd | Cyprus | IDNA |